CYP cynata therapeutics limited

Ann: New Kidney Transplantation Clinical Trial for Cynata & LUMC, page-3

  1. 480 Posts.
    lightbulb Created with Sketch. 114
    This is a great development, probably the best development this year.
    Imagine if Cynata stem cells are able to remove the need for immunosuppressants after kidney transplant!
    Also another one where the trial is funded and managed by a university and all Cynata has to do is provide the cells.
    Hopefully it starts in early 2023 rather than mid or late. But at least getting those 10 patients should be pretty fast once it starts.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
18.0¢
Change
0.015(9.09%)
Mkt cap ! $40.67M
Open High Low Value Volume
17.5¢ 18.0¢ 17.5¢ $19.40K 110.1K

Buyers (Bids)

No. Vol. Price($)
1 93183 17.5¢
 

Sellers (Offers)

Price($) Vol. No.
18.0¢ 5000 1
View Market Depth
Last trade - 10.40am 28/07/2025 (20 minute delay) ?
CYP (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.